Geratherm Medical AG (GB:0EL9)
LSE:0EL9
Total Valuation
Geratherm Medical has a market cap or net worth of €14.86M. The enterprise value is €10.13M.
Market Cap€14.86M
Enterprise Value€10.13M
Share Statistics
Geratherm Medical has 5,444,998 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding5,444,998
Owned by Insiders―
Owned by Institutions―
Financial Efficiency
Geratherm Medical’s return on equity (ROE) is -0.04 and return on invested capital (ROIC) is -5.12%.
Return on Equity (ROE)-0.04
Return on Assets (ROA)-0.03
Return on Invested Capital (ROIC)-5.12%
Return on Capital Employed (ROCE)-0.06
Revenue Per Employee83.04K
Profits Per Employee-4.58K
Employee Count179
Asset Turnover0.57
Inventory Turnover3.44
Valuation Ratios
The current PE Ratio of Geratherm Medical is 16.4. Geratherm Medical’s PEG ratio is 0.09.
PE Ratio16.4
PS Ratio1.05
PB Ratio0.80
Price to Fair Value0.80
Price to FCF12.78
Price to Operating Cash Flow7.03
PEG Ratio0.09
Income Statement
In the last 12 months, Geratherm Medical had revenue of 14.86M and earned -818.99K in profits. Earnings per share was -0.15.
Revenue14.86M
Gross Profit2.37M
Operating Income-1.31M
Pretax Income-906.97K
Net Income-818.99K
EBITDA-154.63K
Earnings Per Share (EPS)-0.15
Cash Flow
In the last 12 months, operating cash flow was 2.79M and capital expenditures -117.00K, giving a free cash flow of 2.68M billion.
Operating Cash Flow2.79M
Free Cash Flow2.68M
Free Cash Flow per Share0.49
Dividends & Yields
Geratherm Medical pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share―
Dividend Yield―
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta0.29
52-Week Price Change-15.25%
50-Day Moving Average2.72
200-Day Moving Average3.16
Relative Strength Index (RSI)27.16
Average Volume (3m)23.00
Important Dates
Geratherm Medical upcoming earnings date is Aug 27, 2026, TBA (Confirmed).
Last Earnings DateJun 11, 2026
Next Earnings DateAug 27, 2026
Ex-Dividend Date―
Financial Position
Geratherm Medical as a current ratio of 6.41, with Debt / Equity ratio of 12.57%
Current Ratio6.41
Quick Ratio4.99
Debt to Market Cap0.16
Net Debt to EBITDA33.19
Interest Coverage Ratio-16.89
Taxes
In the past 12 months, Geratherm Medical has paid -78.58K in taxes.
Income Tax-78.58K
Effective Tax Rate0.09
Enterprise Valuation
Geratherm Medical EV to EBITDA ratio is -67.97, with an EV/FCF ratio of 8.59.
EV to Sales0.71
EV to EBITDA-67.97
EV to Free Cash Flow8.59
EV to Operating Cash Flow7.58
Balance Sheet
Geratherm Medical has €9.61M in cash and marketable securities with €2.62M in debt, giving a net cash position of €6.99M billion.
Cash & Marketable Securities€9.61M
Total Debt€2.62M
Net Cash€6.99M
Net Cash Per Share€1.28
Tangible Book Value Per Share€3.42
Margins
Gross margin is 48.46%, with operating margin of -8.84%, and net profit margin of -5.51%.
Gross Margin48.46%
Operating Margin-8.84%
Pretax Margin-6.10%
Net Profit Margin-5.51%
EBITDA Margin-1.04%
EBIT Margin-8.84%
Analyst Forecast
The average price target for Geratherm Medical is ―, which is 11.43% higher than the current price. The consensus rating is ―
Price Target―
Price Target Upside―
Analyst Consensus―
Analyst Count0
Revenue Growth Forecast6.33%
EPS Growth Forecast-216.17%